.With very early stage 1 data today out in the wild, metabolic health condition outfit Metsera is ac...
.Rivus Pharmaceuticals has actually introduced the information behind its own phase 2 obesity win in...
.Bristol Myers Squibb is spending Main Medicine $110 million in advance to create reagents for ex-sp...
.Novartis has tattooed a deal likely worth more than $1 billion along with Flagship-founded Generate...
.Recently debuted Metsera is unfolding some phase 1 data for its own GLP-1 receptor agonist, uncover...
.Among the hereditary medicines arms race, Flagship Pioneering is introducing a brand new company to...
.BioAge Labs is eyeing about $180 million in first earnings from an IPO and also a private placement...
.An attempt by Merck & Co. to unlock the microsatellite steady (MSS) metastatic intestines cancer...
.Spain-based Asabys Allies has actually shut a fund of 180 thousand euros ($ 200 thousand), amount o...
.BioAge Labs is actually bringing in practically $200 million using its Nasdaq IPO this morning, alo...